Ashish P. Thakrar, MD

Internal Medicine
Accepting new patients
Sees patients age 18 and up
Penn Internal Medicine - Edward S. Cooper Internal Medicine
Make an appointmentCall 215-662-2250
Headshot of Ashish P. Thakrar, MD
Penn Medicine Provider

About me

  • Assistant Professor of Medicine (General Internal Medicine)

My education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Johns Hopkins University School of Medicine
  • Fellowship: Johns Hopkins University School of Medicine

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Thakrar is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Yu-Chia H, Thakrar AP, Leonard CE, Lowenstein M, Brensinger CM, Bilker WB, Bogar KF, Hennessy S Trends in Methadone Use for Pain and Opioid Use Disorder Among Medicaid Enrollees , JAMA Health Forum, 6(11): 2025

Zhang A, Barnes J, Sherman J, O'Donnell N, Velez R, Huo S, Thakrar AP, Lowenstein P, Perrone J, Kilaru AS Linkage to Outpatient Methadone Treatment from the Emergency Department and Hospital , Academic Emergency Medicine, 32(11): 2025,1251-1254

Thakrar AP. Rapid Initiation of Extended-Release Buprenorphine-Evidence and Barriers , JAMA Netw Open, 8: 2025,e2537331

Davis MH, Chertok J, Aronowitz S, French R, Perrone J, Thakrar AP, Huo S, Wilson JD, Bhadra-Heintz N, Lesniak L, Hecker A, Tolbert J, Lowenstein M. Caring for Hospitalized Patients with Substance Use Disorders: An Interprofessional Needs Assessment Survey , Am J Med Open, 14: 2025,100116

Thakrar AP, Zwiebel SJ, Christine PJ, Spadaro A, Davis MH, Bhatia R, Rohacs N, Xu L, Perrone J, Lowenstein M. Manifestations of potential xylazine withdrawal: A retrospective cohort study with nested case series , Drug Alcohol Depend, 272: 2025,112681

Unsihuay D, Wang P, Milone M, Thakrar AP, Perrone J Performance of a Xylazine Test Strip in Urine Biospecimens , Journal of Addiction Medicine, 19(4): 2025

Yang WT, Meisner JA, Maguire C, Dyer KE, McFadden R, Thakrar AP, Dickinson DT, Berg D, Preston A, David MZ, Perrone J, Talati N, Degnan KO. Multidisciplinary Guidance to Care for Persons With Xylazine-Associated Wounds , Open Forum Infect Dis, 12: 2025,ofaf299

Nessen SJ, Thakrar AP, Perrone J, Xu L, McFadden R, Lowenstein M Hospital Security Searches Among Patients With Substance-Related Encounters , JAMA Netw Open, 8(3): 2025

Berk J, Rose M, Thakrar AP. Low-Dose Initiations of Buprenorphine in the Fentanyl Era-A Search for Evidence-Based Approaches to an Evolving Crisis , JAMA Netw Open, 8: 2025,e2456261

French R, McFadden R, Lowenstein M, O'Donnell N, Perrone J, Aronowitz S, Thakrar AP, Schachter A, Turi E, Compton P. A qualitative study exploring the feasibility and acceptability of embedding an overdose prevention sites in a U.S. hospital , J Subst Use Addict Treat: 2025

View all publications